Advertisement Spectranetics wins clearance for new Cross-Pilot catheter - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Spectranetics wins clearance for new Cross-Pilot catheter

Spectranetics, a developer and marketer of single-use medical devices, has received clearance from the FDA for the Cross-Pilot laser support catheter. The launch of the product will commence during the first quarter of 2009 within the US, Europe and Canada.

The Cross-Pilot is a laser support catheter for the 0.9 Turbo Elite laser ablation catheter. The Cross-Pilot was designed to provide additional support for reaching distal lesions. The Cross-Pilot laser support catheter is currently offered in 125cm length and straight and angled tip configurations, the company said.

According to the company, the braid reinforced catheter construction and hydrophilic coating allow for better pushability through distal vessels and the angled tip allows for quicker access to branched anatomy.

Emile Geisenheimer, chairman, president and CEO of Spectranetics, said: “We are pleased to receive FDA clearance for another important product. The Cross-Pilot product line, and the Quick-Cross Extreme product line, which was approved by the FDA last week, will expand our support catheter product offering to the benefit of our physician customers and their patients.”